Abstract
In contrast to the adult population, many medicines used in children with asthma have been inadequately studied with the result that evidence for their usage is lacking. Short-acting bronchodilators and inhaled corticosteroids have been available for over 40 years and thankfully, evidence for their usage in children is now relatively good. This is not the case for long-acting bronchodilators, leukotriene receptor antagonists and omalizumab. This article discusses currently available evidence on all aspects of treatment relevant to children and offers comments on possible future trends. The development of national and international childrens research networks throughout Europe and beyond should enable robust studies to be undertaken to fill our evidence gap and improve control of asthma in all ages of children.
Keywords: Asthma, bronchodilators
Current Pediatric Reviews
Title: Management Options in Childhood Asthma – What is the Current Evidence on which Treatment is Based?
Volume: 6 Issue: 2
Author(s): Warren Lenney
Affiliation:
Keywords: Asthma, bronchodilators
Abstract: In contrast to the adult population, many medicines used in children with asthma have been inadequately studied with the result that evidence for their usage is lacking. Short-acting bronchodilators and inhaled corticosteroids have been available for over 40 years and thankfully, evidence for their usage in children is now relatively good. This is not the case for long-acting bronchodilators, leukotriene receptor antagonists and omalizumab. This article discusses currently available evidence on all aspects of treatment relevant to children and offers comments on possible future trends. The development of national and international childrens research networks throughout Europe and beyond should enable robust studies to be undertaken to fill our evidence gap and improve control of asthma in all ages of children.
Export Options
About this article
Cite this article as:
Lenney Warren, Management Options in Childhood Asthma – What is the Current Evidence on which Treatment is Based?, Current Pediatric Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339610791561169
DOI https://dx.doi.org/10.2174/157339610791561169 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recombinant Allergens for Diagnosis and Immunotherapy of Allergic Disorders, with Emphasis on Cockroach Allergy
Current Protein & Peptide Science Surface Energy Determined by Inverse Gas Chromatography as a Tool to Investigate Particulate Interactions in Dry Powder Inhalers
Current Pharmaceutical Design Predicting Drug Efficacy Using Integrative Models for Chronic Respiratory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Bee Pollen: Chemical Composition and Potential Beneficial Effects on Health
Current Nutrition & Food Science Cutaneous Markers of HIV Infection and Progression
Current HIV Research Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System
Current Diabetes Reviews Malononitrile as a Key Reagent in Multicomponent Reactions for the Synthesis of Pharmaceutically Important Pyridines
Current Organic Chemistry Mining for Protein Kinase Substrates: Integration of Biochemistry, Genetics and Proteomics
Current Proteomics Editorial (Thematic Issue: Emerging Formulation Design and Drug Delivery Systems for Inhaled Therapy)
Current Pharmaceutical Design Impairment of Lung Function During Adjuvant Oxaliplatin Treatment in Patients with Colorectal Cancer: A Prospective Trial
Current Drug Safety Expression of a Disintegrin and Metalloprotease 10 Gene Polymorphisms in a Cohort of Egyptian Patients with Hepatocellular Carcinoma
Current Cancer Therapy Reviews Potential Application of Centrifuges to Protect the CNS in Space and on Earth
Current Alzheimer Research Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery
Current Pharmaceutical Design Progress in Research of K<sub>V</sub>1.1 and K<sub>V</sub>1.3 Channels as Therapeutic Targets
Current Topics in Medicinal Chemistry Selective Inhibitors of Nuclear Factor of Activated T Cells: Potential Therapeutic Drugs for the Treatment of Immunological and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Current Perspectives on Cytokines for Anti-retroviral Therapy in AIDS Related B-cell Lymphomas
Current Drug Targets - Infectious Disorders <i>In vivo</i> Anticancer Potential of Hydroxamic Acid Derivatives
Current Topics in Medicinal Chemistry Eph as a Target in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacology of Nitric Oxide: Molecular Mechanisms and Therapeutic Strategies
Current Pharmaceutical Design Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
Current Drug Targets